“We frequently deal with pathologies of the outer genitals. Testicular carcinoma is the most common cancer in young men. The most important requirement sounds simple – to get an ultrasound image with the highest possible resolution,” says Dr. Drerup. The Xario 200G fully demonstrates its strengths in this respect. Not only is it compact and intuitive in its use, it also features exceptionally powerful imaging. The foundation of the Xario 200G is the High Density Beamformer, which enables technologies such as precision imaging and SMI as well as real-time compound imaging ApliPure+ and broadband harmonic imaging differential THI.
Image management, integrated onboard reporting and various network functions as well as up to 8 hours of battery life and a 2-second boot-up time, make the Xario 200G a high-performance ‘team member’ in the urology department and a perfect partner for all-around tasks. Together with the Aplio i700, clinical requirements can be optimally fulfilled.
Fusion biopsy for prostate cancer is a frequent area of application for ultrasound. “The objective is to find the best treatment for each individual patient,” says Prof. Lusuardi. And this works best with an MRI-guided fusion biopsy, during which tissue samples which were previously remarkable on the MRI scan are removed in a targeted manner using ultrasound imaging.
To improve the accuracy of the exam, the MRI and ultrasound images are superimposed on each other. The MRI scan serves as ‘visual support’ to permit improved navigation within the higher-resolution ultrasound visualisation. Due to the accuracy, not only can we detect a higher number of clinically relevant tumours, we can also reduce the amount of biopsies. //
The content reflects information available at the time of publication and may differ from current information.